SEO YOUNG SON: Open Payments
NPI 1548790306 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 29 payments from 17 companies in 2025. Trend: 2023 $552 · 2024 $601 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $282 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $143 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Novo Nordisk Inc | 4 | $61 |
| Exact Sciences Corporation | 2 | $46 |
| Lilly USA, LLC | 2 | $36 |
| SCILEX PHARMACEUTICALS INC. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $22 |
Products named: LINZESS, JARDIANCE, CREON, SHINGRIX, Cologuard Collection Kit, Ozempic, REXULTI, ZTLido.
Industry payments across NJ — which companies pay providers there.
